DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 146 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q1 2023. The put-call ratio across all filers is 0.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7 | -12.5% | 600 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $8 | -11.1% | 600 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $9 | -35.7% | 600 | -87.5% | 0.00% | 0.0% |
| Q4 2022 | $14 | -99.9% | 4,800 | +6.7% | 0.00% | -50.0% |
| Q3 2022 | $18,000 | -37.9% | 4,500 | -22.4% | 0.00% | 0.0% |
| Q2 2022 | $29,000 | -3.3% | 5,800 | +75.8% | 0.00% | 0.0% |
| Q1 2022 | $30,000 | -28.6% | 3,300 | -40.0% | 0.00% | 0.0% |
| Q4 2021 | $42,000 | -85.4% | 5,500 | -40.2% | 0.00% | -84.6% |
| Q3 2021 | $288,000 | -39.7% | 9,200 | -75.2% | 0.01% | -40.9% |
| Q2 2021 | $478,000 | +5.3% | 37,050 | +27.8% | 0.02% | 0.0% |
| Q1 2021 | $454,000 | +103.6% | 28,999 | +42.2% | 0.02% | +100.0% |
| Q4 2020 | $223,000 | -14.2% | 20,399 | +31.6% | 0.01% | -31.2% |
| Q3 2020 | $260,000 | -25.5% | 15,499 | 0.0% | 0.02% | -33.3% |
| Q2 2020 | $349,000 | -4.6% | 15,499 | -45.8% | 0.02% | +33.3% |
| Q1 2020 | $366,000 | -86.4% | 28,617 | -79.8% | 0.02% | -89.1% |
| Q4 2019 | $2,690,000 | +44733.3% | 141,861 | +11721.8% | 0.16% | +16400.0% |
| Q3 2019 | $6,000 | 0.0% | 1,200 | -42.9% | 0.00% | 0.0% |
| Q2 2019 | $6,000 | – | 2,100 | +950.0% | 0.00% | – |
| Q4 2018 | $0 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $69,030,000 | 15.95% |
| SV Health Investors, LLC | 449,951 | $25,679,000 | 12.37% |
| Sunesis Advisors, LLC | 96,299 | $5,496,000 | 4.45% |
| Redmile Group, LLC | 4,437,968 | $253,275,000 | 3.07% |
| Consonance Capital Management LP | 484,671 | $27,660,000 | 2.58% |
| SECTORAL ASSET MANAGEMENT INC | 488,842 | $27,898,000 | 1.97% |
| Opaleye Management Inc. | 222,000 | $12,670,000 | 1.66% |
| Eversept Partners, LP | 246,240 | $14,052,917 | 1.65% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 38,620 | $2,204,000 | 1.28% |
| Avoro Capital Advisors LLC | 1,300,000 | $74,191,000 | 1.28% |